AWH Capital L.P. Increases Position in Liquidia Corporation $LQDA

AWH Capital L.P. lifted its holdings in Liquidia Corporation (NASDAQ:LQDA) by 8.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 92,500 shares of the company’s stock after purchasing an additional 7,500 shares during the period. Liquidia comprises about 2.9% of AWH Capital L.P.’s portfolio, making the stock its 17th largest holding. AWH Capital L.P. owned 0.11% of Liquidia worth $3,190,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Apis Capital Advisors LLC purchased a new stake in Liquidia during the 3rd quarter worth approximately $9,569,000. Farallon Capital Management LLC boosted its holdings in shares of Liquidia by 102.1% during the 3rd quarter. Farallon Capital Management LLC now owns 8,565,638 shares of the company’s stock worth $194,783,000 after purchasing an additional 4,326,876 shares during the last quarter. GSA Capital Partners LLP boosted its holdings in shares of Liquidia by 63.6% during the 4th quarter. GSA Capital Partners LLP now owns 63,176 shares of the company’s stock worth $2,179,000 after purchasing an additional 24,555 shares during the last quarter. Tudor Investment Corp ET AL acquired a new position in shares of Liquidia during the 3rd quarter worth approximately $1,536,000. Finally, State of New Jersey Common Pension Fund D acquired a new position in shares of Liquidia during the 4th quarter worth approximately $709,000. 64.54% of the stock is currently owned by hedge funds and other institutional investors.

Liquidia Stock Performance

NASDAQ LQDA opened at $68.65 on Thursday. The company has a debt-to-equity ratio of 1.18, a current ratio of 2.22 and a quick ratio of 2.03. Liquidia Corporation has a 1 year low of $11.85 and a 1 year high of $73.22. The company has a market capitalization of $6.11 billion, a PE ratio of 490.39 and a beta of 0.58. The company has a fifty day moving average of $51.76 and a two-hundred day moving average of $41.76.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings data on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The company had revenue of $132.87 million during the quarter, compared to the consensus estimate of $119.44 million. The business’s quarterly revenue was up 4187.1% compared to the same quarter last year. As a group, analysts expect that Liquidia Corporation will post 2.97 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Lifesci Capital upgraded Liquidia to a “strong-buy” rating in a report on Thursday, March 5th. Weiss Ratings restated a “sell (d-)” rating on shares of Liquidia in a research note on Tuesday, April 21st. Needham & Company LLC upped their price target on Liquidia from $54.00 to $70.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. BTIG Research upped their price target on Liquidia from $50.00 to $59.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Finally, Oppenheimer set a $75.00 price objective on Liquidia in a research report on Friday, June 5th. Three equities research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $60.29.

Insider Buying and Selling at Liquidia

In other news, Director Stephen M. Bloch sold 85,062 shares of the stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $71.44, for a total transaction of $6,076,829.28. Following the completion of the sale, the director owned 980,073 shares in the company, valued at approximately $70,016,415.12. This represents a 7.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Sanjeev Khindri sold 4,134 shares of the firm’s stock in a transaction dated Monday, June 8th. The shares were sold at an average price of $65.46, for a total transaction of $270,611.64. Following the completion of the sale, the insider owned 67,132 shares of the company’s stock, valued at approximately $4,394,460.72. The trade was a 5.80% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 2,282,894 shares of company stock worth $128,344,713 over the last three months. 25.60% of the stock is currently owned by corporate insiders.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).